Monday - June 29, 2026

Category Archives: Financial Market

Professor Kai London Releases 2030 Healthcare Cyber Resilience Outlook, Calling Cyber Resilience the New Patient-Safety Metric

New outlook from The Heart Foundation Trust, Singapore, examines escalating healthcare cyber incidents and sets five priorities for hospitals, health systems, CISOs and boards before 2030 NEW YORK – 26 June, 2026 – Professor Kai London, a senior cybersecurity executive, Chief … Continue reading →

GameChanger: Sphere 3D Corp. (NASDAQ: ANY) and Bitdeer Technologies Group (NASDAQ: BTDR) Team Up to Power Next-Gen AI Infrastructure

As the global race to secure Artificial Intelligence (AI) infrastructure accelerates, one increasingly valuable asset is becoming clear: power. Companies that control energy capacity, Data Centers, High-Performance Computing (HPC) infrastructure, and GPU-ready facilities are emerging as key players in the … Continue reading →

Game Changing News: ILLR, ANY, IQST, MIMI, KUST Stocks Investors Are Watching Now

Investors continue searching for companies positioned to benefit from today’s fastest-growing trends, including Artificial Intelligence (AI), Digital Infrastructure, Data Centers, Cloud Computing, High-Performance Computing (HPC), Robotics, Fintech, Social Media, and Live Entertainment. Several Nasdaq-listed companies announced significant strategic developments that … Continue reading →

TrustEvals, Founded by Unmukt Raizada, Launches Next-Generation AI Governance for Financial Services, Real Estate firms, and Enterprise Audits

Adoption, evaluation, and compliance are one measurement problem in three vocabularies. Most of the market sells you three products. We build the single picture. TrustEvals, founded by former Goldman Sachs and JPMorgan Chase executive Unmukt Raizada, has launched a next-generation … Continue reading →

Idiopathic Pulmonary Fibrosis Market is Expected to Surpass USD 7 Billion by 2036, Driven by Rising Disease Burden and Emerging Disease-Modifying Therapies | DelveInsight

The Idiopathic Pulmonary Fibrosis Market is witnessing substantial growth driven by increasing disease prevalence, improving diagnostic capabilities, growing awareness among healthcare professionals, and expanding adoption of antifibrotic therapies. The anticipated launch of emerging therapies such as Deupirfenidone, Admilparant, NIKTIMVO, and … Continue reading →